Moreover, FSCN1 invalidation modulated melanoma cell differentiation state, inducing the switch to a poorly differentiated phenotype characterized by reduced levels of MITF and increased levels of AXL and NGFR (Figs 5E and EV4F). The gene discussed is AXL; the disease is melanoma.